A drug for treating erythromelalgia

Abstract

The invention provides a medicine for treating erythematous extremity pain, which is composed of an internal medicine and an external medicine, wherein, the internal medicine is a medicament made of the following traditional Chinese medicine raw materials by weight: 10-20 parts of red fish eyes, 10‑20 parts of Danshen, 10‑20 parts of Achyranthes bidentata, 5‑12 parts of Chinese herb, 5‑12 parts of Cortex Phellodendri, 5‑12 parts of red peony, 15‑25 parts of purslane, 8‑15 parts of Clematis, raw 4-8 parts of licorice, 10-20 parts of wormwood, 15-25 parts of Sage vine; the external medicine is a washing liquid made of the following traditional Chinese medicine raw materials by weight: 30-50 parts of red fish eye, 15-30 parts of rice , 10‑20 parts of honeysuckle, 20‑30 parts of Gotu Kola, 30‑50 parts of wormwood, 10‑20 parts of rhubarb, 10‑20 parts of Qingdai.

Description

technical field

[0001] The invention relates to a pharmaceutical composition, more specifically, it relates to a medicine for treating erythromelalgia. Background technique

[0002] Erythromelalgia is an extremity vasodilation disease, which is one of the relatively rare autonomic nervous system diseases. It usually occurs acutely after a sudden drop in temperature, exposure to cold, or long-distance walking. It is characterized by symmetrical swelling and hot pain on the feet, especially at night. Its pathogenesis may be due to peripheral vascular dysfunction caused by autonomic dysfunction, resulting in excessive expansion of blood vessels and local congestion. The etiology of this disease is not yet fully understood, but the patient is extremely painful.

[0003] According to the clinical manifestations of erythromelalgia, it can be classified into the categories of "arthralgia", "foot pain" and "hand and foot pain" in traditional Chinese medicine, especially similar to...